Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing new medicines for cancer, neurologic and autoimmune disease. It is a member of Ono Pharmaceutical Co., Ltd., and offers a competitive compensation and benefits package including medical, dental, vision, and 401(k).
Develop and execute a strategic territory business plan to support the launch of tirabrutinib for relapsed/refractory primary central nervous system lymphoma patients.
Build strong relationships with hematology/oncology healthcare professionals and key accounts to drive disease education and product readiness.
Communicate clinical data clearly, address barriers to treatment adoption, and collaborate cross-functionally to ensure seamless patient access.